Weekend reads: Why a vice-chancellor uses Impact Factors; plagiarizing principals; time to publish less?

The week at Retraction Watch featured the tale of a scientist whose explanations for misconduct kept changing, and revelations in a big legal case involving Duke University. Here’s what was happening elsewhere:

Weekend reads: Death penalty for scientific fraud?; Why criticism is good; Cash for publishing

The week at Retraction Watch featured revelations about a case of misconduct at the University of Colorado Denver, and the case of a do-over that led to a retraction. Here’s what was happening elsewhere:

Weekend reads: Science’s citation problem; researcher rehab; a strange new journal

The week at Retraction Watch featured the resignation of a researcher found to have fudged data in a study of Crossfit, and allegations of bullying by a scientist who wouldn’t let a trainee publish a paper. Here’s what was happening elsewhere:

Ohio State exercise researcher resigns after retraction of CrossFit study

The senior author of a lawsuit-spawning study of the CrossFit exercise program has resigned from his post at The Ohio State University. On June 2, we reported that the Journal of Strength and Conditioning Research retracted the problematic study because it lacked approval from the institutional review board. The journal had previously corrected the study, … Continue reading Ohio State exercise researcher resigns after retraction of CrossFit study

Weekend reads: A demand for a CRISPR paper retraction; a weak data-sharing policy; can we trust journals?

The week at Retraction Watch featured a study suggesting that 2% of studies in eight medical journals contained suspect data, and the announcement of a retraction on a professor’s blog. Here’s what was happening elsewhere:

Two in 100 clinical trials in eight major journals likely contain inaccurate data: Study

A sweeping analysis of more than 5,000 papers in eight leading medical journals has found compelling evidence of suspect data in roughly 2% of randomized controlled clinical trials in those journals. Although the analysis, by John Carlisle, an anesthetist in the United Kingdom, could not determine whether the concerning data were tainted by misconduct or … Continue reading Two in 100 clinical trials in eight major journals likely contain inaccurate data: Study

Weekend reads: ‘Pile of dung’ republished; Diverging views on publishing negative results; Economists share regrets

The week at Retraction Watch featured an unusual warning from the New England Journal of Medicine, and the withdrawal of a paper over a fear of legal threats. Here’s what was happening elsewhere:

Journal retracts Ohio State CrossFit study at center of lawsuits

The fallout continues for a study conducted at a local CrossFit gym by researchers at The Ohio State University. First it was corrected, now it’s been retracted, and it continues to be the basis of litigation against both the authors and the publisher. Editors at the Journal of Strength and Conditioning Research have decided to … Continue reading Journal retracts Ohio State CrossFit study at center of lawsuits

Publisher blames bad choice of reviewer for publication of hoax paper on penis as “social construct” 

Less than a week after publishing a much-discussed hoax paper, a scholarly publisher has acknowledged that it had chosen reviewers for the paper whose “expertise did not fully align with this subject matter.” The subject matter: that the penis should not be considered an anatomical organ, but more as a concept – “a gender-performative, highly fluid social … Continue reading Publisher blames bad choice of reviewer for publication of hoax paper on penis as “social construct”